Compare SHASUN PHARMA with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA SUN PHARMA SHASUN PHARMA/
SUN PHARMA
 
P/E (TTM) x 123.9 21.8 569.4% View Chart
P/BV x 8.5 2.5 334.7% View Chart
Dividend Yield % 0.2 0.6 37.2%  

Financials

 SHASUN PHARMA   SUN PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
SUN PHARMA
Mar-19
SHASUN PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs94679 13.9%   
Low Rs46375 12.1%   
Sales per share (Unadj.) Rs214.2121.1 176.8%  
Earnings per share (Unadj.) Rs5.313.4 39.9%  
Cash flow per share (Unadj.) Rs15.820.7 76.5%  
Dividends per share (Unadj.) Rs1.002.75 36.4%  
Dividend yield (eoy) %1.40.5 274.2%  
Book value per share (Unadj.) Rs53.3172.6 30.9%  
Shares outstanding (eoy) m56.622,399.26 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.4 7.5%   
Avg P/E ratio x13.139.4 33.2%  
P/CF ratio (eoy) x4.425.5 17.3%  
Price / Book Value ratio x1.33.1 42.9%  
Dividend payout %18.720.6 91.2%   
Avg Mkt Cap Rs m3,9581,264,650 0.3%   
No. of employees `000NA17.5 0.0%   
Total wages/salary Rs m2,16459,671 3.6%   
Avg. sales/employee Rs ThNM16,608.1-  
Avg. wages/employee Rs ThNM3,409.6-  
Avg. net profit/employee Rs ThNM1,833.8-  
INCOME DATA
Net Sales Rs m12,127290,659 4.2%  
Other income Rs m22910,255 2.2%   
Total revenues Rs m12,356300,914 4.1%   
Gross profit Rs m1,00963,076 1.6%  
Depreciation Rs m59417,533 3.4%   
Interest Rs m4155,553 7.5%   
Profit before tax Rs m23050,246 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m-736,009 -1.2%   
Profit after tax Rs m30232,093 0.9%  
Gross profit margin %8.321.7 38.3%  
Effective tax rate %-31.712.0 -264.7%   
Net profit margin %2.511.0 22.6%  
BALANCE SHEET DATA
Current assets Rs m6,884310,692 2.2%   
Current liabilities Rs m8,456173,396 4.9%   
Net working cap to sales %-13.047.2 -27.4%  
Current ratio x0.81.8 45.4%  
Inventory Days Days6299 62.2%  
Debtors Days Days108112 96.4%  
Net fixed assets Rs m4,970232,477 2.1%   
Share capital Rs m1132,399 4.7%   
"Free" reserves Rs m2,875411,691 0.7%   
Net worth Rs m3,020414,091 0.7%   
Long term debt Rs m1,81715,226 11.9%   
Total assets Rs m13,347646,938 2.1%  
Interest coverage x1.610.0 15.5%   
Debt to equity ratio x0.60 1,636.5%  
Sales to assets ratio x0.90.4 202.2%   
Return on assets %5.45.8 92.3%  
Return on equity %10.07.8 129.1%  
Return on capital %13.310.2 131.0%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84366,025 8.8%   
Fx outflow Rs m2,17338,610 5.6%   
Net fx Rs m3,66927,415 13.4%   
CASH FLOW
From Operations Rs m39821,965 1.8%  
From Investments Rs m-1,635-6,813 24.0%  
From Financial Activity Rs m1,309-27,305 -4.8%  
Net Cashflow Rs m71-8,442 -0.8%  

Share Holding

Indian Promoters % 39.2 63.7 61.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 5.1 70.2%  
FIIs % 17.6 23.0 76.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 8.3 477.1%  
Shareholders   20,750 133,026 15.6%  
Pledged promoter(s) holding % 12.3 0.5 2,318.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   PFIZER  GSK PHARMA  DR. DATSONS LABS  WYETH LTD  ABBOTT INDIA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS